The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology
Abstract
Genetic technology has advanced dramatically in the past few decades, and its applications and use in caring for and counseling pregnant women has been transformational in the realm of prenatal diagnosis. Two of the newer genetic technologies in the prenatal setting are chromosomal microarray and whole-exome sequencing. Chromosomal microarray analysis is a method of measuring gains and losses of DNA throughout the human genome. It can identify chromosomal aneuploidy and other large changes in the structure of chromosomes as well as submicroscopic abnormalities that are too small to be detected by traditional modalities. Prenatal chromosomal microarray analysis is recommended for a patient with a fetus with one or more major structural abnormalities identified on ultrasonographic examination and who is undergoing invasive prenatal diagnosis. Whole-genome sequencing analyzes the entire genome, including noncoding regions (introns) and coding regions (exons). However, because the introns are typically of little clinical relevance, there has been a focus instead on whole-exome sequencing, which examines the coding regions (exons) of the genome. The exons generally have greater clinical relevance and applicability to patient care. However, the routine use of whole-genome or whole-exome sequencing for prenatal diagnosis is not recommended outside of the context of clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,541
Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
Yang, Y., Muzny, D. M., Reid, J. G., Bainbridge, M. N., Willis, A., Ward, P. A., Braxton, A., Beuten, J., Xia, F., Niu, Z., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306555 · Cited by 1,964
Chromosomal microarray versus karyotyping for prenatal diagnosis
Wapner, R. J., Martin, C. L., Levy, B., Ballif, B. C., Eng, C. M., Zachary, J. M., Savage, M., Platt, L. D., Saltzman, D., Grobman, W. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203382 · Cited by 1,412
Kearney, H. M., Thorland, E. C., Brown, K. K., Quintero-Rivera, F., & South, S. T. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182217a3a · Cited by 929
Cukier, H. N., Dueker, N. D., Slifer, S. H., Lee, J. M., Whitehead, P. L., Lalanne, E., Leyva, N., Konidari, I., Gentry, R. C., Hulme, W. F., et al. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-1 · Cited by 316
Karyotype versus Microarray Testing for Genetic Abnormalities after Stillbirth
Reddy, U. M., Page, G. P., Saade, G. R., Silver, R. M., Thorsten, V. R., Parker, C. B., Pinar, H., Willinger, M., Stoll, B. J., Heim-Hall, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201569 · Cited by 300
Shaffer, L. G., Rosenfeld, J. A., Dabell, M. P., Coppinger, J., Bandholz, A. M., Ellison, J. W., Ravnan, J. B., Torchia, B. S., Ballif, B. C., & Fisher, A. J. (2012) · Prenatal Diagnosis · doi:10.1002/pd.3943 · Cited by 267
Women’s experiences receiving abnormal prenatal chromosomal microarray testing results
Bernhardt, B. A., Soucier, D., Hanson, K., Savage, M. S., Jackson, L., & Wapner, R. J. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.113 · Cited by 228
Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities
Drury, S., Williams, H., Trump, N., Boustred, C., GOSGene, Lench, N., Scott, R. H., & Chitty, L. S. (2015) · Prenatal Diagnosis · doi:10.1002/pd.4675 · Cited by 223
Lefkowitz, R. B., Tynan, J. A., Liu, T., Wu, Y., Mazloom, A. R., Almasri, E., Hogg, G., Angkachatchai, V., Zhao, C., Grosu, D. S., et al. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.02.030 · Cited by 202
Cited by
Pierpont, M. E., Brueckner, M., Chung, W. K., Garg, V., Lacro, R. V., McGuire, A. L., Mital, S., Priest, J. R., Pu, W. T., Roberts, A., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000606 · Cited by 654
Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226
American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics, Committee on Genetics, & Society for Maternal-Fetal Medicine (2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004084 · Cited by 552
Prenatal diagnosis by chromosomal microarray analysis
Levy, B., & Wapner, R. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.01.005 · Cited by 341
Metadata
- Venue
- Obstetrics & Gynecology
- Published
- 2016-12
- Volume
- 128
- Issue
- 6
- Pages
- e262-e268
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W4244360267
- Cited by
- 290
- References
- 14
- FWCI
- 26.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology. https://app.cochat.ai/papers/10.1097/aog.0000000000001817
- The paper
- Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology. (2016). Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000001817
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.